Literature DB >> 15047132

Probiotics partly reverse increased bacterial translocation after simultaneous liver resection and colonic anastomosis in rats.

Daniel Seehofer1, Nada Rayes, Reinhard Schiller, Martin Stockmann, Andrea R Müller, Anja Schirmeier, Frank Schaeper, Stefan G Tullius, Stig Bengmark, Peter Neuhaus.   

Abstract

BACKGROUND: Bacterial translocation is one important cause of nosocomial infections following major abdominal surgery. Oral administration of probiotics has been proposed to diminish bacterial translocation.
MATERIAL AND METHODS: In total 68 rats were divided into seven groups: five of the groups received standard rat chow and were subjected to either sham-operation, 70% liver resection, colonic anastomosis, or a combination of 30 or 70% liver resection with synchronous colonic anastomosis, respectively. In two additional groups with synchronous operation, a combination of four different lactic acid bacteria and four fibers was administered two times daily pre- and postoperatively. Bacterial concentrations in cecum, mesenteric lymph nodes, liver, and spleen were analyzed and blood cultures were taken 48 h after operation. Furthermore, the following parameters were assessed: histological changes in the intestine, intestinal paracellular permeability (Ussing chamber), bursting pressure of the colonic anastomosis, and mitosis rate of the remnant liver.
RESULTS: Bacterial translocation was observed in all rats, except in the sham group. Following liver resection, the highest bacterial concentrations were seen in liver and spleen, following colon anastomosis in the mesenteric lymph nodes. Bacterial translocation was increased in the animals with combined operation, in parallel to the extent of liver resection. In rats with colon anastomosis, bacterial concentration in the cecum was also higher than in the sham group. Application of probiotics significantly decreased bacterial concentration in the lymph nodes. In addition, animals with a high cecal concentration of lactobacilli had less translocation than the others. No histological changes were observed in the intestine. Paracellular permeability for ions, but not for the larger molecule lactulose, was increased in the colon in all groups with colon anastomosis. The bursting pressure of the colon anastomosis was not significantly different between the groups. Seventy percent liver resection led to a high rate of hepatocyte mitosis, whereas combination with colon anastomosis impaired the regeneration process.
CONCLUSION: Synchronous liver resection and colon anastomosis led to increased bacterial translocation compared to the single operations in the rat model. It is possible to diminish this process by oral administration of probiotics. Bacterial overgrowth in the cecum and impaired hepatic regeneration, but not histological changes or alterations of paracellular permeability, are potential pathogenic mechanisms for translocation in this setting.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15047132     DOI: 10.1016/j.jss.2003.11.021

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  11 in total

1.  Protection against increased intestinal permeability and bacterial translocation induced by intestinal obstruction in mice treated with viable and heat-killed Saccharomyces boulardii.

Authors:  Simone V Generoso; Mirelle L Viana; Rosana G Santos; Rosa M E Arantes; Flaviano S Martins; Jacques R Nicoli; José A N Machado; Maria Isabel T D Correia; Valbert N Cardoso
Journal:  Eur J Nutr       Date:  2010-10-10       Impact factor: 5.614

2.  Probiotics and synbiotics reduce infective complications from colorectal surgery.

Authors:  J Kinross
Journal:  Tech Coloproctol       Date:  2022-09       Impact factor: 3.699

Review 3.  Implications of microbiota and bile acid in liver injury and regeneration.

Authors:  Hui-Xin Liu; Ryan Keane; Lili Sheng; Yu-Jui Yvonne Wan
Journal:  J Hepatol       Date:  2015-08-07       Impact factor: 25.083

Review 4.  Prebiotics, probiotics, synbiotics in surgery--are they only trendy, truly effective or even dangerous?

Authors:  Nada Rayes; Daniel Seehofer; Peter Neuhaus
Journal:  Langenbecks Arch Surg       Date:  2008-12-16       Impact factor: 3.445

5.  Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduodenectomy: a randomized, double-blind trial.

Authors:  Nada Rayes; Daniel Seehofer; Tom Theruvath; Martina Mogl; Jan M Langrehr; Natascha C Nüssler; Stig Bengmark; Peter Neuhaus
Journal:  Ann Surg       Date:  2007-07       Impact factor: 12.969

6.  Glutamine and recombinant human growth hormone protect intestinal barrier function following portal hypertension surgery.

Authors:  Zhao-Feng Tang; Yun-Biao Ling; Nan Lin; Zheng Hao; Rui-Yun Xu
Journal:  World J Gastroenterol       Date:  2007-04-21       Impact factor: 5.742

7.  Does the use of probiotics/synbiotics prevent postoperative infections in patients undergoing abdominal surgery? A meta-analysis of randomized controlled trials.

Authors:  Eleni Pitsouni; Vangelis Alexiou; Vasilis Saridakis; George Peppas; Matthew E Falagas
Journal:  Eur J Clin Pharmacol       Date:  2009-03-27       Impact factor: 2.953

8.  Intraabdominal bacterial infections significantly alter regeneration and function of the liver in a rat model of major hepatectomy.

Authors:  Daniel Seehofer; Martin Stockmann; Anja Schirmeier; Andreas K Nüssler; Si-Young Ria Cho; Nada Rayes; Martin Koch; Reinhold Schiller; Michael D Menger; Peter Neuhaus
Journal:  Langenbecks Arch Surg       Date:  2007-03-23       Impact factor: 2.895

9.  Microbiome-Gut-Brain Axis: A Pathway for Improving Brainstem Serotonin Homeostasis and Successful Autoresuscitation in SIDS-A Novel Hypothesis.

Authors:  Vijayakumar Praveen; Shama Praveen
Journal:  Front Pediatr       Date:  2017-01-06       Impact factor: 3.418

Review 10.  The Gut-Liver Axis in Health and Disease: The Role of Gut Microbiota-Derived Signals in Liver Injury and Regeneration.

Authors:  Zhipeng Zheng; Baohong Wang
Journal:  Front Immunol       Date:  2021-12-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.